Warning: The NCBI web site requires JavaScript to function. more...
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.
Wuttge DM, Wildt M, Geborek P, Wollheim FA, Scheja A, Akesson A.
Arthritis Res Ther. 2007;9(5):R85.
Related citations
The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
Choi HJ, Shin YK, Lee HJ, Kee JY, Shin DW, Lee EY, Lee YJ, Lee EB, Song YW.
Clin Rheumatol. 2008 Apr;27(4):437-42. Epub 2007 Sep 25.
Increased serum interleukin 23 in patients with systemic sclerosis.
Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, Takehara K, Sato S.
J Rheumatol. 2008 Jan;35(1):120-5. Epub 2007 Dec 15.
Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.
J Rheumatol. 1998 Feb;25(2):308-13.
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, Price PA, Jacobsen S.
Scand J Rheumatol. 2005 Jul-Aug;34(4):293-7.
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S.
Clin Rheumatol. 2011 Jun;30(6):825-30. Epub 2011 Jan 19.
Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K.
J Rheumatol. 2000 Jan;27(1):149-54.
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
J Autoimmun. 2008 Dec;31(4):372-6. Epub 2008 Oct 15.
Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
J Rheumatol. 2006 Feb;33(2):275-84.
Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
J Rheumatol. 2001 Nov;28(11):2460-5.
Pulmonary function tests, high-resolution computerized tomography, alpha1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis.
Shahin AA, Sabri YY, Mostafa HA, Sabry EY, Hamid MA, Gamal H, Shahin HA.
Rheumatol Int. 2001 Apr;20(3):95-100.
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
Ann Rheum Dis. 2006 Jan;65(1):124-6.
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
Sato S, Hasegawa M, Takehara K.
J Dermatol Sci. 2001 Oct;27(2):140-6.
Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
Reitamo S, Remitz A, Varga J, Ceska M, Effenberger F, Jimenez S, Uitto J.
Arch Dermatol. 1993 Feb;129(2):189-93.
Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
Michalska-Jakubus M, Kowal-Bielecka O, Chodorowska G, Bielecki M, Krasowska D.
Rheumatology (Oxford). 2011 Apr;50(4):746-55. Epub 2010 Dec 10.
Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A.
J Rheumatol. 2003 Jan;30(1):68-73.
Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.
Sato S, Hanakawa H, Hasegawa M, Nagaoka T, Hamaguchi Y, Nishijima C, Komatsu K, Hirata A, Takehara K.
J Rheumatol. 2000 Dec;27(12):2838-42.
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K.
Arthritis Rheum. 2001 Jun;44(6):1363-9.
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K.
Rheumatology (Oxford). 2006 Mar;45(3):303-7. Epub 2005 Nov 8.
Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
Hara T, Ogawa F, Yanaba K, Iwata Y, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
J Rheumatol. 2009 Jan;36(1):99-105.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on